Heart failure drug effective with or without atrial fibrillation – study

Getty/PeopleImages

By Olivia Bowthorpe

The non-steroidal aldosterone antagonist finerenone improves outcomes for patients with heart failure regardless of the presence of atrial fibrillation, a study has suggested.

The drug also appeared to reduce the incidence of new-onset atrial fibrillation, although this was not statistically significant, said John McMurray, professor of medical cardiology at Queen Elizabeth University Hospital, Glasgow, and colleagues.¹